⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AUPH News
Aurinia Pharmaceuticals Inc
Form 8-K
sec.gov
AUPH
LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death
businesswire.com
AUPH
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences Ready to Announce with Confidence?
newsfilecorp.com
AUPH
Form 8-K
sec.gov
AUPH
Form 8-K
sec.gov
AUPH
Form 8-K
sec.gov
AUPH
KZR
Form 8-K
sec.gov
KZR
AUPH
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
businesswire.com
KZR
AUPH
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
businesswire.com
KZR
AUPH
Form 8-K
sec.gov
AUPH